Social Items



Scientists seeking to test a cancer vaccine have successfully treated 97 percent of mouse tumors in mice with low-grade lymphoma later this year, the British Daily Mail reported.
Patients receiving the drug, which contains two drugs that have been tested for protection, do not need any chemotherapy, and the side effects are expected to be fever and some allergies.
If approved, researchers expect the treatment to be available within two years. Instead of creating permanent immunity, the drug works by activating the immune system to attack tumors.
The drug is expected to work effectively with low-grade lymphoma, which affects some white blood cells and generally responds to treatment, because it is often detected by the immune system, unlike other forms of the disease, such as bowel cancer.
About 1.7 million people are diagnosed with cancer each year in the United States. "We have a big problem in cancer and we will never be satisfied until we find solutions," said lead researcher Dr. Ronald Levy of Stanford University.
The researchers implanted two identical tumors at separate sites in the mice's bodies. One of these tumors was injected with the vaccine, which stimulated the activation of T cells.
These cells release an immune response against attacking objects, such as viruses. The findings, reported in the journal Transplantational Medicine, indicate that the vaccine cures multiple types of cancer and prevents the disease from occurring.

source


Soon a "successful" vaccine for cancer without the suffering of the chemist



Scientists seeking to test a cancer vaccine have successfully treated 97 percent of mouse tumors in mice with low-grade lymphoma later this year, the British Daily Mail reported.
Patients receiving the drug, which contains two drugs that have been tested for protection, do not need any chemotherapy, and the side effects are expected to be fever and some allergies.
If approved, researchers expect the treatment to be available within two years. Instead of creating permanent immunity, the drug works by activating the immune system to attack tumors.
The drug is expected to work effectively with low-grade lymphoma, which affects some white blood cells and generally responds to treatment, because it is often detected by the immune system, unlike other forms of the disease, such as bowel cancer.
About 1.7 million people are diagnosed with cancer each year in the United States. "We have a big problem in cancer and we will never be satisfied until we find solutions," said lead researcher Dr. Ronald Levy of Stanford University.
The researchers implanted two identical tumors at separate sites in the mice's bodies. One of these tumors was injected with the vaccine, which stimulated the activation of T cells.
These cells release an immune response against attacking objects, such as viruses. The findings, reported in the journal Transplantational Medicine, indicate that the vaccine cures multiple types of cancer and prevents the disease from occurring.

source


technology

No comments

Subscribe to: Post Comments (Atom)